[1]
2022. Risk factors for potential drug-drug interactions of statins in patients with acute coronary syndrome. Brazilian Journal of Pharmaceutical Sciences. 58, (Nov. 2022). DOI:https://doi.org/10.1590/s2175-979020201000X22e19868.